Skip to main content

On This Page

← AI Financial News

Oracle – 2025-12-18 - increase Confidence 8/10

2 min read $ORCL
Share

These articles are AI-generated summaries. Please check the original sources for full details.

ORCLOracle Corporation
$219.86-29.21 (-11.73%)
$328$273$218Aug 18Oct 2Nov 17
52W High: $328.3352W Low: $217.57Volume: 16.14M
NYSE
Prediction (1/1/2026):High: $345.72Low: $118.86Ref Price: $180.03
This chart shows historical data as of November 17, 2025. Not updated in real-time.

ORCL – increase in Days/Weeks

Oracle reported $16.1B in revenue, up 14% YoY, driven by 34% growth in cloud revenue, just days after a series of high-impact enterprise and healthcare cloud wins. The recent expansion into Canada and strategic Google Cloud partnership add near-term momentum.

Why This Matters

Despite negative free cash flow and a high debt/equity ratio of 432.5, Oracle’s cloud business is demonstrating strong enterprise adoption and pricing power, particularly in healthcare and public sector verticals. The Q2 FY26 results, boosted by structural cloud growth (not just the one-time Ampere gain), signal improving investor sentiment in the near term, especially as integration with hyperscalers like Google Cloud expands its reach.

Key Insights

  • Revenue (TTM): $16.1B (+14% YoY), cloud revenue at $8.0B (+34% YoY) – accelerating growth in core segment
  • News Impact: Multiple new client wins (hospitals, cities, utilities) and geographic expansion validate cloud platform demand
  • Risk/Offset: High debt/equity (432.5) and negative FCF (-$394M) remain structural concerns, but being offset by strong operating cash flow and asset monetization

Practical Implications

  • Bull Case: Continued cloud momentum and analyst upgrades post-earnings could drive a 10–15% move toward $195+ by January
  • Bear Case: Market-wide risk-off due to high beta (1.66) could amplify losses if tech valuations compress
  • Confidence: 8/10 – Earnings beat and multiple catalysts outweigh near-term balance sheet risks

Prediction: increase

Reference:

Continue reading

Next article

Regencell Bioscience – 2025-12-18 - increase Confidence 6/10

Related Content